Patient-Reported Outcome Assessment and Objective Evaluation of Chemotherapy-Induced Alopecia
February 2018
in “
European journal of oncology nursing
”
New to HMI-115? There is a guide in the encyclopedia. Read the guide → Studysummary This study found that the Hair Mass Index is suitable for quantifying hair loss, but patient self-assessment is the most reliable method for evaluating chemotherapy-induced alopecia in clinical practice. Our plain-language summary of this paper — not a Tressless recommendation.
The study evaluated the efficacy of scalp cooling in preventing chemotherapy-induced alopecia (CIA) by comparing patient-reported outcomes with quantitative measurements using the Hair Mass Index (HMI). Results showed that baseline HMI did not predict hair loss, and HMI declined throughout chemotherapy cycles, which was not reflected in patient-reported measures. Patient opinions correlated moderately with doctors and nurses but strongly with hairdressers. The study concluded that while the Hair Check is useful for quantifying hair loss, patient opinions should be considered the best method for assessing hair loss in clinical practice.